These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16734145

  • 1. Transforming growth factor-beta 1 in diabetic nephropathy.
    Metwally SS, Mosaad YM, Nassr AA, Zaki OM.
    Egypt J Immunol; 2005; 12(1):103-12. PubMed ID: 16734145
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 3. [Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage].
    Bao HL, Ye SH, Lou SX, Lu XW, Zhou XF.
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):1128-31. PubMed ID: 24956865
    [Abstract] [Full Text] [Related]

  • 4. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
    Tsapenko MV, Nwoko RE, Borland TM, Voskoboev NV, Pflueger A, Rule AD, Lieske JC.
    Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
    [Abstract] [Full Text] [Related]

  • 5. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G, Paczek L, Kropiewnicka E, Bartłomiejczyk I.
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [Abstract] [Full Text] [Related]

  • 6. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
    Paczek L, Kropiewnicka HE, Senatorski G, Bartłomiejczyk I.
    Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S, Dontamalla SK, Mondru AK, Sannigrahi S, Veerareddy PR.
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [Abstract] [Full Text] [Related]

  • 8. Activation of transforming growth factor-beta1 in diabetic kidney disease.
    Hellmich B, Schellner M, Schatz H, Pfeiffer A.
    Metabolism; 2000 Mar; 49(3):353-9. PubMed ID: 10726914
    [Abstract] [Full Text] [Related]

  • 9. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
    Korpinen E, Groop PH, Fagerudd JA, Teppo AM, Akerblom HK, Vaarala O.
    Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
    [Abstract] [Full Text] [Related]

  • 10. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
    Sato H, Iwano M, Akai Y, Kurioka H, Kubo A, Yamaguchi T, Hirata E, Kanauchi M, Dohi K.
    Am J Nephrol; 1998 Feb; 18(6):490-4. PubMed ID: 9845822
    [Abstract] [Full Text] [Related]

  • 11. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
    Boratyńska M.
    Ann Transplant; 1999 Feb; 4(2):23-8. PubMed ID: 10850587
    [Abstract] [Full Text] [Related]

  • 12. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Qiao YC, Chen YL, Pan YH, Ling W, Tian F, Zhang XX, Zhao HL.
    Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-β1 in children with diabetic nephropathy.
    Sawires H, Botrous O, Aboulmagd A, Madani N, Abdelhaleem O.
    Pediatr Nephrol; 2019 Jan; 34(1):81-85. PubMed ID: 30136104
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [Abstract] [Full Text] [Related]

  • 16. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z, Chen CX.
    Phytomedicine; 2013 Aug 15; 20(11):1023-9. PubMed ID: 23746755
    [Abstract] [Full Text] [Related]

  • 17. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M, Unal AD, Kostek O, Bayraktar N, Demirag NG.
    Nefrologia; 2016 Aug 15; 36(6):653-659. PubMed ID: 27745866
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM, del Re E, Brown D, Lin HY.
    Diabetes; 2007 Feb 15; 56(2):380-8. PubMed ID: 17259382
    [Abstract] [Full Text] [Related]

  • 19. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB, Zhang L, Yang LY.
    Ren Fail; 2012 Feb 15; 34(1):83-7. PubMed ID: 22011322
    [Abstract] [Full Text] [Related]

  • 20. Effect of Acacia senegal on TGF-β1 and vascular mediators in a rat model of diabetic nephropathy.
    Mohammed ME, Abbas AM, Badi RM, Bashir SO, Osman OM, Morsy MD, Saeed AM.
    Arch Physiol Biochem; 2022 Dec 15; 128(6):1548-1558. PubMed ID: 32574082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.